Fundraising FoxAperiam Bio
Austin, US · Founded 2021 · Delaware corporation · 4 known investors
Find your way into Aperiam Bio
Sign up to see every warm intro you have to Aperiam Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aperiam Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Aperiam Bio uses computer-vision algorithms to identify "hyperfolding" protein variants with improved expression, solubility, and stability, aiming for order-of-magnitude gains in protein performance. It applies this technology to develop technical reagents, shelf-stable enzymes for cosmetics, and pulmonary biologic therapeutics for its partners.
Founders & leadership
Aperiam Bio was founded in 2021 by Austin Cole.
Investors · 4
How we know: Civilization Ventures Management, Llc's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$7.7M disclosed across 2 rounds · 2022–2023
▶$4MraisedSep 2023 · 2 investors · BiotechnologyRule 506(b)
- Austin ColeExecutive Officer, Director
- Amount sold
- $4M
- Minimum investment
- $100K
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$3.7MraisedMar 2022 · 3 investors · BiotechnologyRule 506(b)
- Austin ColeExecutive Officer, Director
- Amount sold
- $3.7M
- Minimum investment
- $100K
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Aperiam Bio do?
- Aperiam Bio uses computer-vision algorithms to identify "hyperfolding" protein variants with improved expression, solubility, and stability, aiming for order-of-magnitude gains in protein performance. It applies this technology to develop technical reagents, shelf-stable enzymes for cosmetics, and pulmonary biologic therapeutics for its partners.
- Who founded Aperiam Bio?
- Aperiam Bio was founded by Austin Cole in 2021.
- Who are Aperiam Bio's investors?
- Aperiam Bio's investors include Civilization Ventures Management, Llc, OMX Ventures, Axial VC, KdT Ventures.
- How much funding has Aperiam Bio raised?
- Aperiam Bio has disclosed $7.7M raised across 2 rounds.
- Where is Aperiam Bio headquartered?
- Aperiam Bio is headquartered in Austin, US.